| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $297.4M | +96.3% |
| SG&A Expense | $123.2M | +93.2% |
| Operating Income | -$420.6M | -95.4% |
| Interest Expense | $2.4M | +69.1% |
| Income Tax | $0 | — |
| Net Income | -$411.9M | -796.1% |
| EPS (Basic) | -$0.95 | -763.6% |
| EPS (Diluted) | -$0.95 | -82.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $235.4M | -26.6% |
| Short-term Investments | $826.3M | -26.7% |
| Current Assets | $1.07B | -26.7% |
| Total Assets | $1.48B | -14.0% |
| Current Liabilities | $46.8M | +52.9% |
| Total Liabilities | $155.9M | +45.6% |
| Stockholders' Equity | $1.32B | -18.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$218.0M | -70.5% |
| Capital Expenditures | $158.8M | +24.9% |
| Investing Cash Flow | $124.1M | +132.2% |
| Financing Cash Flow | $8.6M | -98.8% |
| Free Cash Flow | -$376.9M | -47.7% |